topic0
Study [mnob] 0.00931602228562
Risk Factors [qnco] 0.00924503377976
Related [qlco] 0.00921964923969
Tumour NOS [neop] 0.00717367820845
YEARS [tmco] 0.00664051198314
Radiofrequency Ablation [topp] 0.00637962786101
Methods [inpr] 0.00591481286723
HEPATITIS B VIRUS [virs] 0.00589762192798
HEPATITIS C VIRUS [virs] 0.00509957322758
LIVER [bpoc] 0.00494818267129
lesions [fndg] 0.00456723909758
treatment [ftcn] 0.00442860019097
DIAGNOSIS [fndg] 0.00441776372276
chemoembolisation [topp] 0.00430668284696
CIRRHOSIS [dsyn] 0.00413816990145
Survival [acty] 0.00405503343876
Performed [ftcn] 0.00399244523783
Including [ftcn] 0.00385481732372
Conclusions [idcn] 0.00365882013006
LOCAL [spco] 0.00358584890098
Portal Vein Thrombosis [dsyn] 0.00349218655559
ABLATION [topp] 0.00330484146855
Important [qlco] 0.00325548483242
Pathology [bmod] 0.0032442156339
Tumors [neop] 0.00316974488675
Margin [spco] 0.00306667350664
Median [spco] 0.00305029577463
Group [idcn] 0.00300436631255
therapy [ftcn] 0.00298979150443
Cases [ftcn] 0.00297274353862
Tumour progression [neop] 0.00288007917542
Transcatheter [spco] 0.00287447450619
Based [ftcn] 0.00286930639017
Cholangitis, Sclerosing [dsyn] 0.00283718617004
BIOPSY [diap] 0.00278426680843
Screening [hlca] 0.00276861418892
Criteria [inpr] 0.00266986926427
Hepatic [blor] 0.00263503584954
YEAR [tmco] 0.00262730071128
findings [ftcn] 0.00254604255585
topic1
Study [mnob] 0.0118775651203
Survival [acty] 0.0101851187182
YEARS [tmco] 0.00838693649572
Risk Factors [qnco] 0.00791314227044
treatment [ftcn] 0.00712766633017
Methods [inpr] 0.00695494103568
CI [geoa] 0.00689476792904
Cases [ftcn] 0.00614379060194
resection [topp] 0.00569580369566
CIRRHOSIS [dsyn] 0.00569470789451
Related [qlco] 0.00539019082825
Median [spco] 0.00515869783138
HEPATITIS B VIRUS [virs] 0.00510985165088
LIVER [bpoc] 0.00510617540455
Liver Transplantation [topp] 0.00503389312971
Compared [acty] 0.00503098820048
HEPATITIS C VIRUS [virs] 0.00499248922984
Cholangiocarcinoma [neop] 0.00482264704681
Hepatectomy [topp] 0.00444269284081
Tumour NOS [neop] 0.00441642753632
Performed [ftcn] 0.0042964721911
Group [idcn] 0.00403867147629
Increased [qnco] 0.00390541566267
CANCER [neop] 0.00388004699972
control [qlco] 0.00369958345233
YEAR [tmco] 0.00361745812382
Association [menp] 0.00360738282233
Conclusions [idcn] 0.00343904840999
Independent [idcn] 0.00343583312693
Levels [qlco] 0.00339243344887
Hazard Ratio [qnco] 0.00330017834915
Including [ftcn] 0.00310469722818
Mortality [qnco] 0.00291859236815
Suggest [idcn] 0.0028072672978
included [ftcn] 0.00278032990259
Range [qnco] 0.00275061984171
Based [ftcn] 0.00273986070945
Higher [qlco] 0.00259059107641
Criteria [inpr] 0.00258413189034
Important [qlco] 0.00256157016318
topic2
Risk Factors [qnco] 0.0114065989093
CIRRHOSIS [dsyn] 0.0109246974299
Preoperative [tmco] 0.00863745495236
Group [idcn] 0.00802016756461
resection [topp] 0.00718787425755
Survival [acty] 0.00708788618318
Cases [ftcn] 0.00693861456301
Study [mnob] 0.00616598899456
LIVER [bpoc] 0.00590210068783
Hepatectomy [topp] 0.00570872838615
Hepatic [blor] 0.00570381022016
YEAR [tmco] 0.0053817796548
Levels [qlco] 0.00525368773363
Intrahepatic [spco] 0.00524096774399
treatment [ftcn] 0.00513809738578
Identified [qlco] 0.00456374900961
HEPATITIS C VIRUS [virs] 0.00450568811765
Odds Ratio [qnco] 0.00446151777774
Conclusions [idcn] 0.00430360285315
Tumour NOS [neop] 0.00429149133173
Methods [inpr] 0.00394650874758
Invasion [fndg] 0.00393893849809
Increased [qnco] 0.0038616085764
Independent [idcn] 0.00368134815798
Mortality [qnco] 0.00366302649521
DIAGNOSIS [fndg] 0.0034652984896
SERUM [bdsu] 0.00338113563064
Performed [ftcn] 0.00326497764772
YEARS [tmco] 0.0031189047008
Postoperative [tmco] 0.00303122753092
Including [ftcn] 0.00298281752478
Liver Transplantation [topp] 0.00294279444434
Compared [acty] 0.00291257784274
Genotype [orga] 0.00282542718532
Nonalcoholic Fatty Liver Disease [dsyn] 0.00273839439049
RATIO [qnco] 0.00269464107275
bile leakage [patf] 0.00268227377664
Radiofrequency Ablation [topp] 0.00259767726497
Groups [idcn] 0.00257554711802
Tumors [neop] 0.00254235453619
topic3
Risk Factors [qnco] 0.0122641419992
Study [mnob] 0.0106213015629
resection [topp] 0.00981246437465
Cases [ftcn] 0.00793839719143
LIVER [bpoc] 0.00710195138039
treatment [ftcn] 0.00610200181026
Survival [acty] 0.00592829533387
Methods [inpr] 0.00572202667847
Hepatic [blor] 0.00563966274508
Related [qlco] 0.0051427885052
HCC [neop] 0.00489261140149
CIRRHOSIS [dsyn] 0.00478141786481
CANCER [neop] 0.00477796109791
Tumour NOS [neop] 0.00426572116479
Nonalcoholic Fatty Liver Disease [dsyn] 0.00420665897719
Radiofrequency Ablation [topp] 0.003859642172
HCV [virs] 0.00374993609556
Groups [idcn] 0.00365295438599
Postoperative [tmco] 0.00335898509756
Group [idcn] 0.00335243198005
Conclusions [idcn] 0.00331015000544
YEARS [tmco] 0.0032736696631
DIAGNOSIS [fndg] 0.00309049049984
Intrahepatic Cholangiocarcinoma [neop] 0.00306834407781
Increased [qnco] 0.00301837000014
SERUM [bdsu] 0.00299181878094
polymorphisms [genf] 0.00294587243113
Pathology [bmod] 0.00293778689497
Compared [acty] 0.00288764727939
Performed [ftcn] 0.00287939948148
Based [ftcn] 0.00287799586712
Treated [ftcn] 0.00285778959255
LARGE [qnco] 0.00284777606284
Tumors [neop] 0.00268113389107
Hepatectomy [topp] 0.00265734277638
included [ftcn] 0.00265302301342
Including [ftcn] 0.00261603830454
Higher [qlco] 0.00254579116901
Liver Cancer [neop] 0.00249367941269
Association [menp] 0.00245108738679
topic4
Group [idcn] 0.0112523008562
resection [topp] 0.00834709372095
HEPATITIS C VIRUS [virs] 0.00827959365192
treatment [ftcn] 0.00815718797202
LIVER [bpoc] 0.00798101387945
YEARS [tmco] 0.00762490927438
Related [qlco] 0.00724468405133
CIRRHOSIS [dsyn] 0.00720700744148
Compared [acty] 0.00715473180309
Survival [acty] 0.00669073055423
Methods [inpr] 0.00634540915634
Risk Factors [qnco] 0.00605462963683
Hepatic [blor] 0.00549714642552
Study [mnob] 0.00525589444272
Radiofrequency Ablation [topp] 0.00518447727519
Tumour NOS [neop] 0.00510478846469
HCV [virs] 0.00481724072926
HEPATITIS B VIRUS [virs] 0.00474898887744
Criteria [inpr] 0.00463496356871
Conclusions [idcn] 0.00443474322416
Cases [ftcn] 0.00422031209439
Independent [idcn] 0.00415957016788
YEAR [tmco] 0.0041406531638
Postoperative [tmco] 0.00387176624488
SUSTAINED VIROLOGIC RESPONSE [fndg] 0.00378505565377
Increased [qnco] 0.00365690664092
LOCAL [spco] 0.00361854059812
Hepatectomy [topp] 0.00349966372516
surveillance [ftcn] 0.00346262235314
Nonalcoholic Fatty Liver Disease [dsyn] 0.00342003957319
Invasion [fndg] 0.00332738982119
Identified [qlco] 0.00329928829822
therapy [ftcn] 0.00315424217454
Curative [cnce] 0.00292576345187
Transarterial Chemoembolization [topp] 0.00279928784059
LOWER [spco] 0.00277253568165
Observed [ftcn] 0.0026774970462
Pathology [bmod] 0.00267657112404
Groups [idcn] 0.00265545748873
Intrahepatic [spco] 0.00265057779515
topic5
Survival [acty] 0.00967123960315
Liver Transplantation [topp] 0.00867197422406
HEPATITIS C VIRUS [virs] 0.00837271585586
Group [idcn] 0.00834744748257
Risk Factors [qnco] 0.00778965859267
Study [mnob] 0.0073964101163
LIVER [bpoc] 0.00713470484145
YEAR [tmco] 0.00709730047117
Methods [inpr] 0.00643333189983
Conclusions [idcn] 0.00470887531744
Groups [idcn] 0.00470587273455
Compared [acty] 0.0046020373092
Tumour NOS [neop] 0.0043027174684
Related [qlco] 0.00424315496996
Hepatic [blor] 0.00418362111275
HEPATITIS B VIRUS [virs] 0.00399884113035
YEARS [tmco] 0.00393447989032
Criteria [inpr] 0.00373669902434
Levels [qlco] 0.00369439990227
Tumors [neop] 0.00357609777609
CIRRHOSIS [dsyn] 0.00357575236114
Hepatitis C virus infection [dsyn] 0.00343963334905
treatment [ftcn] 0.00342248175625
Transplantation [topp] 0.00329306661308
Pathology [bmod] 0.00323730578213
lesions [fndg] 0.00315941029568
Odds Ratio [qnco] 0.00315146627409
Intrahepatic Cholangiocarcinoma [neop] 0.0031161620559
Independent [idcn] 0.0030722239638
control [qlco] 0.00305667554027
resection [topp] 0.00298617663941
Performed [ftcn] 0.00296528257288
Mortality [qnco] 0.00277563165668
Radiofrequency Ablation [topp] 0.0027600648521
Low [qlco] 0.00273597594422
Cases [ftcn] 0.00261590596024
Higher [qlco] 0.00260852807879
Prognostic [inpr] 0.00259779163234
SERUM [bdsu] 0.00259541758882
Suggest [idcn] 0.00258318108544
topic6
LIVER [bpoc] 0.00822830099974
Risk Factors [qnco] 0.00800168693282
treatment [ftcn] 0.00793899686056
Study [mnob] 0.00582697481456
Induced [ftcn] 0.0054166249325
Tumour NOS [neop] 0.00530678602426
Methods [inpr] 0.00529898146413
CANCER [neop] 0.00481061189285
Tumors [neop] 0.00453044664549
DIAGNOSIS [fndg] 0.00453019557969
Compared [acty] 0.00435657226464
HCC [neop] 0.00424570814099
resection [topp] 0.00418505962197
Related [qlco] 0.0041584291827
Treated [ftcn] 0.00415393732906
Survival [acty] 0.00396359006818
Hepatic [blor] 0.00393563068943
Group [idcn] 0.00383485673525
Cholangiocarcinoma [neop] 0.00376856489929
HEPATITIS C VIRUS [virs] 0.00376540192431
CIRRHOSIS [dsyn] 0.00375561341467
Increased [qnco] 0.00365247770937
Present [qnco] 0.00350134609373
Radiofrequency Ablation [topp] 0.00337222548803
Performed [ftcn] 0.00331918312292
Conclusions [idcn] 0.00324390035465
FIBROSIS [patf] 0.00313012244485
YEARS [tmco] 0.00308779179295
therapy [ftcn] 0.00305782749949
Independent [idcn] 0.00301969981332
Subject [grup] 0.00290459441717
Pathology [bmod] 0.00278048549072
YEAR [tmco] 0.00275908471068
Cases [ftcn] 0.00267044096906
Groups [idcn] 0.00261756414694
NEW [qlco] 0.00260362732847
control [qlco] 0.00252362632511
Liver Transplantation [topp] 0.00250838023401
Percutaneous [spco] 0.00247010586144
Based [ftcn] 0.00246671875649
topic7
Survival [acty] 0.0129808865092
CIRRHOSIS [dsyn] 0.00927353696619
Risk Factors [qnco] 0.00891311472652
Study [mnob] 0.00835160673103
Group [idcn] 0.00736389926744
LIVER [bpoc] 0.00592453415973
treatment [ftcn] 0.00556527688968
Tumour NOS [neop] 0.00513263138669
Methods [inpr] 0.00489394857441
Related [qlco] 0.00480650349887
Tumors [neop] 0.00456606187378
DIAGNOSIS [fndg] 0.004250064188
Treated [ftcn] 0.00419794815252
Compared [acty] 0.00402591211439
Human [humn] 0.00402211304886
Groups [idcn] 0.00394530404661
Increased [qnco] 0.0036812493724
Independent [idcn] 0.0035744021725
Conclusions [idcn] 0.00343282496281
Cases [ftcn] 0.00341521127236
Median [spco] 0.00336580525272
Hepatectomy [topp] 0.00336519148101
YEARS [tmco] 0.00334327861832
Transarterial Chemoembolization [topp] 0.00331407324969
Based [ftcn] 0.00322545293528
Higher [qlco] 0.00311534295744
Liver Transplantation [topp] 0.00311386081089
TYPE [qlco] 0.00304244407179
findings [ftcn] 0.0029397263029
Identified [qlco] 0.00293236491643
Present [qnco] 0.00277479641449
Including [ftcn] 0.00276696057186
Important [qlco] 0.00266974473138
Progression [patf] 0.00266386452536
Nonalcoholic Fatty Liver Disease [dsyn] 0.00264275733659
resection [topp] 0.00264003120989
Performed [ftcn] 0.00261154646079
Invasion [fndg] 0.00256223738151
Evaluated [hlca] 0.00256007499539
Association [menp] 0.00255581265211
topic8
Risk Factors [qnco] 0.010429848831
Study [mnob] 0.00956846174992
HEPATITIS B VIRUS [virs] 0.00895301975216
Group [idcn] 0.00786458947615
resection [topp] 0.00700400159355
Tumour NOS [neop] 0.00691648594195
Hepatectomy [topp] 0.00644047111263
Methods [inpr] 0.00627818408084
Related [qlco] 0.00553089109892
LIVER [bpoc] 0.00530262444586
HEPATITIS C VIRUS [virs] 0.0052393459463
treatment [ftcn] 0.00518911732897
Cases [ftcn] 0.00472551368318
Arterial [bpoc] 0.00435786007247
Conclusions [idcn] 0.00426927539382
Survival [acty] 0.00422496541015
Levels [qlco] 0.00407938149221
Association [menp] 0.00405419900652
Independent [idcn] 0.00399241386298
YEARS [tmco] 0.00370786428702
Enhanced [acty] 0.00364756770212
Groups [idcn] 0.00353454351602
Compared [acty] 0.00327352180222
Hepatic [blor] 0.00311888811597
Nonalcoholic Fatty Liver Disease [dsyn] 0.00305125288378
Postoperative [tmco] 0.0029900599156
Subject [grup] 0.00295564819317
ALT [neop] 0.00280972640192
chemoembolisation [topp] 0.00280774839709
Invasion [fndg] 0.00276552880455
TIME [tmco] 0.00270280859094
Diabetes [dsyn] 0.00266950509555
CIRRHOSIS [dsyn] 0.00264000655669
Performed [ftcn] 0.00254896101872
Identified [qlco] 0.00250801884196
Cells [cell] 0.00248151217325
Evaluated [hlca] 0.0024224771873
YEAR [tmco] 0.0024203326229
Odds Ratio [qnco] 0.00240195112389
included [ftcn] 0.00240161010505
topic9
Risk Factors [qnco] 0.0113110711809
Mortality [qnco] 0.00923714454998
YEARS [tmco] 0.00887509909969
YEAR [tmco] 0.00785233468032
Study [mnob] 0.00780369558131
Tumour NOS [neop] 0.00742576160355
Survival [acty] 0.00701751268538
treatment [ftcn] 0.00687328314225
LIVER [bpoc] 0.00627593712268
Methods [inpr] 0.00622663679214
Related [qlco] 0.00603115216732
Invasion [fndg] 0.00588192192777
CIRRHOSIS [dsyn] 0.00587381239125
HEPATITIS B VIRUS [virs] 0.00580553257032
Compared [acty] 0.00460989275189
HCV [virs] 0.00453169020563
Nonalcoholic Fatty Liver Disease [dsyn] 0.00440769896879
Cases [ftcn] 0.00438869310452
Conclusions [idcn] 0.00403185490608
liver resection [topp] 0.00393204035647
Group [idcn] 0.00386679524723
resection [topp] 0.00383778117588
Metastasis [neop] 0.00379626322014
Enhanced [acty] 0.00348923555736
Independent [idcn] 0.00325990130507
Increased [qnco] 0.00321998749688
Postoperative [tmco] 0.00313772842075
Cholangiocarcinoma [neop] 0.00312766350786
HEPATITIS C VIRUS [virs] 0.00308585209552
Groups [idcn] 0.00302639155772
Hepatitis C virus infection [dsyn] 0.00299690759654
CANCER [neop] 0.00298001661785
LIVER CIRRHOSIS [dsyn] 0.00286376425916
Performed [ftcn] 0.0027565596867
Median [spco] 0.00272223337499
Tumour size [spco] 0.00271701180183
Preoperative [tmco] 0.00268866390618
Vascular [bpoc] 0.0025965433942
FIBROSIS [patf] 0.00257207854623
Hepatectomy [topp] 0.0025595695443
